Does ABALOPARATIDE Cause Injection site swelling? 113 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Injection site swelling have been filed in association with ABALOPARATIDE (Tymlos). This represents 0.5% of all adverse event reports for ABALOPARATIDE.
113
Reports of Injection site swelling with ABALOPARATIDE
0.5%
of all ABALOPARATIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site swelling From ABALOPARATIDE?
Of the 113 reports, 5 (4.4%) required hospitalization.
Is Injection site swelling Listed in the Official Label?
Yes, Injection site swelling is listed as a known adverse reaction in the official FDA drug label for ABALOPARATIDE.
What Other Side Effects Does ABALOPARATIDE Cause?
Headache (4,048)
Nausea (3,134)
Dizziness (3,005)
Fatigue (2,637)
Heart rate increased (2,092)
Palpitations (1,730)
Arthralgia (1,711)
Bone pain (1,360)
Back pain (1,229)
Pain (1,191)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which ABALOPARATIDE Alternatives Have Lower Injection site swelling Risk?
ABALOPARATIDE vs ABATACEPT
ABALOPARATIDE vs ABATACEPT SUBQ /ML
ABALOPARATIDE vs ABCIXIMAB
ABALOPARATIDE vs ABEMACICLIB
ABALOPARATIDE vs ABILIFY